Related Experiment Video
Updated: Dec 13, 2025

CRISPR/Cas9 Gene Editing of Hematopoietic Stem and Progenitor Cells for Gene Therapy Applications
Published on: August 9, 2022
A Review of Gene, Drug and Cell-Based Therapies for Usher Syndrome
Lucy S French1, Carla B Mellough1, Fred K Chen1,2,3
1Centre for Ophthalmology and Visual Sciences (incorporating Lions Eye Institute), The University of Western Australia, Nedlands, WA, Australia.
Abstract:
Usher syndrome is a genetic disorder causing neurosensory hearing loss and blindness from retinitis pigmentosa (RP). Adaptive techniques such as braille, digital and optical magnifiers, mobility training, cochlear implants, or other assistive listening devices are indispensable for reducing disability. However, there is currently no treatment to reduce or arrest sensory cell degeneration. There are several classes of treatments for Usher syndrome being investigated. The present article reviews the progress this research has made towards delivering commercial options for patients with Usher syndrome.
Related Concept Videos
Gene Therapy
iPS Cell Differentiation
Targeted Cancer Therapies
There are several types of targeted therapies against...

